Pharmahungary Group is rated 3 out of 5 in the category biotechnology. Read and write reviews about Pharmahungary Group. More than a CRO, your creative R&D team™ www.pharmahungary.com Mission of Pharmahungary - providing wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) and metabolic diseases (diabetes, dyslipidemia, atherosclerosis, obesity, uremia, etc) with strong scientific support - clinical R&D services focusing on special clinical studies including medical device that need sensitive patient population and thereby strong regulatory & scientific support - to manage internal R&D projects to develop new technologies for outlicensing in the fileds of diagnosis and therapy of cardiovascular and metabolic diseases Why Pharmahungary? - Full service: creative, cost-effective, flexible, high quality - Internationally trained management & staff (MDs, PhDs, clinical pharmacologists, PharmDs, chemists, biologists, medical engineers, MBA quality managers) - Complex platforms of cardiovascular and metabolic disease models, - Custom design models with co-morbidities, including large animals - Strong biochemical and molecular biological background for complex proof-of-concept studies - Scientific support based on international scientific excellence (publications over 240, impact factors over 1 000, citations over 13 000) - Strict confidentiality, IP rights under regulations of the European Union For more information please visit: www.pharmahungary.com.
Company size
11-50 employees